Skip to content

Moleculin Biotech, Inc.: filings

Every Moleculin Biotech, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026351070001437749-26-027688
10-Q2026-05-14fiscal Q1 202635750001437749-26-017034
10-K2026-03-18fiscal FY 202542860001437749-26-008841
10-Q2025-11-13fiscal Q3 2025341190001437749-25-034839
10-Q2025-08-12fiscal Q2 2025341020001437749-25-026225
10-Q2025-05-13fiscal Q1 202533700001437749-25-016466
10-K2025-03-21fiscal FY 202438770001437749-25-008751
10-Q2024-11-08fiscal Q3 2024331040001437749-24-034236
10-Q2024-08-13fiscal Q2 2024341010001437749-24-026367
10-Q2024-05-10fiscal Q1 202432680001437749-24-016031
10-K2024-03-22fiscal FY 202338770001437749-24-009044
10-Q2023-11-13fiscal Q3 2023341050001437749-23-031391
10-Q2023-08-10fiscal Q2 2023341020001437749-23-023021
10-Q2023-05-10fiscal Q1 202334720001437749-23-013582
10-K2023-03-22fiscal FY 202237750001437749-23-007537
10-Q2022-11-10fiscal Q3 2022341060001437749-22-026888
10-Q2022-08-12fiscal Q2 2022341020001437749-22-020389
10-Q2022-05-11fiscal Q1 202234720001437749-22-011925
10-K2022-03-24fiscal FY 202138770001437749-22-007103
10-Q2021-11-10fiscal Q3 2021331000001437749-21-026158
10-Q2021-08-11fiscal Q2 202133940001437749-21-019445
10-Q2021-05-12fiscal Q1 202134710001437749-21-011755
10-K2021-03-24fiscal FY 202040810001437749-21-006940
10-Q2020-11-12fiscal Q3 2020371090001437749-20-023605
10-Q2020-08-12fiscal Q2 2020361010001659617-20-000196
10-Q2020-05-11fiscal Q1 202037770001659617-20-000128
10-K2020-03-19fiscal FY 201939770001659617-20-000066
10-Q2019-11-12fiscal Q3 2019361020001659617-19-000169
10-Q2019-08-16fiscal Q2 201933920001659617-19-000144
10-Q2019-05-13fiscal Q1 201932660001659617-19-000069
10-K2019-02-21fiscal FY 201833680001659617-19-000018
10-Q2018-11-13fiscal Q3 201832820001659617-18-000109
10-Q2018-08-10fiscal Q2 201830780001659617-18-000093
10-Q2018-05-14fiscal Q1 201827560001659617-18-000056
10-K2018-03-28fiscal FY 201730620001659617-18-000027
10-Q2017-11-13fiscal Q3 201726670001659617-17-000005
10-Q2017-08-11fiscal Q2 201720560001144204-17-042482
10-Q2017-05-12fiscal Q1 201719400001144204-17-026918
10-K2017-04-03fiscal FY 201624490001144204-17-018352
10-Q2016-11-21fiscal Q3 201620490001144204-16-135472
10-Q2016-11-21fiscal Q2 201618330001144204-16-135457
10-Q2016-08-15fiscal Q2 201621390001144204-16-119213
10-Q2016-06-16fiscal Q1 201615210001144204-16-108589

Inspect the source

Entity
Moleculin Biotech, Inc. / CIK 0001659617
Captured
2026-09-21T17:22:15.208Z
SEC response SHA-256
015f42d31d8c65fdf2c18f4ba0e93be1c91b4ff6cfa09e8b356366b10cf09e33

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001659617.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))